Singapore-based biotech company Immunoscape announced that it has raised $11 million in a global equity financing round led by US-based venture firm Anzu Partners and joined by University of Tokyo Edge Capital (UTEC) in Japan, and NPR Holdings in Indonesia.
The company, which was founded in 2017, said that its immune profiling platform, which provides deep insights into the T-cells of the human...
